AbCellera Biologics Inc. (ABCL)

NMS – Real Time Price. Currency in USD

9.93

+0.17 (1.74%)

Market open: Aug 12, 2026, 11:25 AM EDT

9.31

-0.45 (-4.63%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

75M

29M

38M

485M

Cost of goods sold

-29M

-97M

-31M

Gross Profit

46M

-68M

Operating expenses (excl. COGS)

-263M

-247M

-244M

-169M

Operating Income

-217M

-315M

-237M

283M

Non-operating income, total

40M

114M

63M

-44M

Pretax income

-178M

-200M

-174M

239M

Equity in earnings

Taxes

31M

38M

28M

-81M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-146M

-163M

-146M

159M

Discontinued operations

Net income

-146M

-163M

-146M

159M

Dilution adjustment

Preferred dividends

AbCellera Biologics Inc. (ABCL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbCellera Biologics Inc. (ABCL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

AbCellera Biologics Inc. (ABCL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbCellera Biologics Inc. (ABCL)

Income Statement (Annual)

Income Statement (Annual)